Analyst Price Targets — AVR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 15, 2026 8:51 am | — | Barclays | $18.00 | $7.25 | TheFly | Anteris Technologies price target raised to $18 from $17 at Barclays |
| January 23, 2026 1:57 pm | Frank Takkinen | Lake Street | $15.00 | $6.27 | TheFly | Anteris Technologies price target lowered to $15 from $20 at Lake Street |
| January 7, 2025 12:35 pm | Ross Osborn | Cantor Fitzgerald | $9.00 | $5.75 | TheFly | Anteris Technologies initiated with an Overweight at Cantor Fitzgerald |
Latest News for AVR
BlackRock Inc. bought a new position in shares of Anteris Technologies Global Corp. (NASDAQ: AVR) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 5,771,213 shares of the company's stock, valued at approximately $56,846,000. BlackRock Inc. owned approximately 5.93%
MINNEAPOLIS and BRISBANE, Australia, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, is pleased to advise that Vice Chairman and Chief Executive Officer, Wayne Paterson, will be presenting at the…
ADAR1 Capital Management LLC bought a new position in shares of Anteris Technologies Global Corp. (NASDAQ: AVR) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,145,096 shares of the company's stock, valued at approximately $30,979,000. Anteris Technologies
Assenagon Asset Management S.A. bought a new stake in Anteris Technologies Global Corp. (NASDAQ: AVR) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 644,668 shares of the company's stock, valued at approximately $6,350,000. Assenagon Asset Management S.A.
MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today reported financial results for the quarter ended June 30, 2026, and provided a corporate update. Q2 2026…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AVR.
U.S. House Trading
No House trades found for AVR.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.